Researchers used CRISPR gene-editing technology to create beagles that produce no detectable Can f 1, the primary protein responsible for dog allergies [1].
The development targets the roughly 15% of the global population that suffers from dog allergies [1]. If scalable, the technology could allow millions of people to keep pets without experiencing allergic reactions [3].
In early laboratory tests, two gene-edited beagles named Alfie and Bailey showed zero detectable levels of the Can f 1 protein [2], [3]. The researchers analyzed the dogs' saliva, hair, and dander to verify the absence of the allergen [1].
Despite these laboratory results, the current data set is limited. An early allergy test involving one person was conducted to observe the reaction to the edited dogs [2].
Some reports suggest these findings could bring immediate relief to millions of sufferers [3]. However, other analysis indicates that the results from only two puppies and a single human subject are insufficient to establish that gene-edited dogs are broadly safe for the general allergic population [2].
CRISPR allows scientists to precisely alter DNA sequences to disable specific proteins. In this case, the goal was to eliminate the source of the most common allergic trigger found in canines [1].
“Two gene-edited beagles showed zero detectable levels of the Can f 1 protein.”
While the total removal of the Can f 1 protein in these two subjects is a technical milestone for CRISPR application in pets, the study is in a proof-of-concept stage. Because dog allergies can be triggered by multiple proteins beyond Can f 1, and because the sample size of both dogs and human testers is extremely small, the results cannot yet be generalized to the broader population of allergy sufferers.
